Peer Review History

Original SubmissionApril 2, 2020
Decision Letter - Fernando A. Wilson, Editor

PONE-D-20-09519

Insurance instability and use of emergency and office-based care after gaining coverage: an observational cohort study

PLOS ONE

Dear Dr. Shafer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address reviewer and editor comments below. Regarding Reviewer #1's first comment, please cite and discuss Kirby and Vistnes(2016). 

Please submit your revised manuscript by Aug 02 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Fernando A. Wilson, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Additional Editor Comments (if provided):

- Please confirm that references conform to PLOS ONE requirements. For example, journal abbreviations should not include periods, i.e., use "N Engl J Med" instead of "N. Engl. J. Med". For further information, refer to: https://journals.plos.org/plosone/s/submission-guidelines#loc-references

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review this paper. Using data from the Medical Expenditure Panel Survey (MEPS), the authors investigate the association between prior ‘insurance stability’ and change in use of emergency and office visits after the introduction of Medicaid expansion and Marketplace. The policy significance of this research question is obvious. The authors have used an appropriate data set and appropriate methods for their analysis.

However, the major issue with this paper is whether it makes sufficiently new contribution to the literature. The authors claim that “However, the relationship between how long someone went uninsured before gaining coverage, what we refer to as insurance instability, and subsequent changes in health care use after gaining coverage has not yet been studied” (lines 64-67). Unfortunately it’s not quite true. Kirby and Vistnes (2016) answered a very similar research question using the same data set and similar methods. The following is the abstract of that paper, from Health Affairs (https://www.healthaffairs.org/doi/10.1377/hlthaff.2016.0716

“Newly available longitudinal survey data show that people who lacked health insurance in 2013 and gained coverage through Medicaid or the Marketplaces in 2014 were far more likely to obtain a usual source of care and receive preventive care services than their counterparts who remained uninsured in 2014.”

Since this paper was not in the citations, I assume that the authors are not aware of this research. The only thing that seems to be different in this paper from the Health Affairs paper is that the authors are using different measures of health care use, though preventive service visits are likely a subset of office visits.

The authors therefore need to do a more careful review of the literature - incorporate the above-mentioned paper and make sure that they haven’t missed any other relevant study. They also need to convince the readers that their research in not just a minor extension of existing research.

Minor issues

1. The authors should exclude the 18-year-olds from the sample. The 18-year-olds have public coverage options from Medicaid or Children’s Health Insurance Program (CHIP) as children that are more generous than those for adults (even in the expansion states).

2. The authors made a good choice of excluding those with Medicare from the sample. Additionally, they should also exclude any one with Supplemental Security Income (SSI) as they are eligible for Medicaid as disabled, and the Medicaid program for the disabled have not changed as a result of the ACA.

Reviewer #2: PONE-D-20-09519 - Insurance instability and use of emergency and office-based care after gaining coverage: an observational cohort study

This paper uses linkage between the National Health Interview Survey (NHIS) and the Medical Expenditure Panel Survey (MEPS) to estimate the association between spells of unemployment until 2014 on changes in office-based and ED care in 2014 following insurance expansions from the ACA. The authors do a great job linking these and other datasets to adequately specify their models, and their four category outcome is sufficient to capture changes in treatment setting. Only a few minor points follow.

It seems that limited sample size may be the culprit for failing to precisely estimate some effects, particularly the substitution among adults gaining public insurance from long-term uninsurance. The authors state that they use separate regressions for short and long-term uninsured with the same reference group. The authors could consider pooling these treatments and allowing the other controls to be restricted or possibly interact with duration of uninsurance with certain covariates. This may lend some power, although it may not change the findings appreciably while adding some unneeded complexity.

The public vs. private analyses suffer from having what you can think of as non-compliers to treatment in each sample. Adults with income above 138% FPL cannot take-up public coverage (virtually entirely Medicaid in this case). The authors omit > 400% FPL, but should try also omitting > 138% FPL, sample size permitting. The authors could go further by subsetting to states that expanded Medicaid in 2014 if they are subsetting down to adults who had an opportunity to enroll in Medicaid. Likewise, the private could omit lower income more likely to take-up Medicaid.

As a minor point, the authors could include as a supplemental table the descriptives for all the variables used in the model, or at least those from the AHRF described in the paper. Also, table notes should include regression sample sizes where applicable.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We have uploaded a revised cover letter and point-by-point response to reviewers with this re-submission.

Attachments
Attachment
Submitted filename: Response to Reviewers_R1 v2.docx
Decision Letter - Fernando A. Wilson, Editor

Insurance instability and use of emergency and office-based care after gaining coverage: an observational cohort study

PONE-D-20-09519R1

Dear Dr. Shafer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Fernando A. Wilson, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Fernando A. Wilson, Editor

PONE-D-20-09519R1

Insurance instability and use of emergency and office-based care after gaining coverage: an observational cohort study

Dear Dr. Shafer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Fernando A. Wilson

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .